SCHEMBL20326029

SCHEMBL20326029

CCOC(=O)C(F)(F)c1ccc(Oc2ccc(C)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 3/20 0.45
▸ MAPT P10636 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ PTGS2 P35354 1/20 0.42
▸ HTR2A P28223 2/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ TSHR P16473 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PMP22 Q01453 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5003336 0.92 NPSR1 (0.47) MAPTNPSR1TSHRKMT2AACSS2
SCHEMBL21501175 0.89 NPC1 (0.52) MAPTNPSR1PTGS2ALDH1A1NPC1
SCHEMBL20325604 0.88 HTR2A (0.56) MAPTHTR2ASLC6A4KCNH2TSHR
SCHEMBL13199136 0.87 TSHR (0.49) NPSR1HTR2AMAPK1TSHRCYP3A4
SCHEMBL12004031 0.84 CYP1A1 (0.48) MAPTCYP1A2ALDH1A1NPC1RAB9A
SCHEMBL20325777 0.84 ALDH1A1 (0.56) HTR2AMAPK1TSHRCYP3A4ABCB11
SCHEMBL13199166 0.82 TSHR (0.46) MAPTNPSR1MAPK1TSHRCRHBP
SCHEMBL17583195 0.82 NPSR1 (0.51) MAPTNPSR1TSHRCYP1A2ALDH1A1
SCHEMBL31306426 0.80 CA12 (0.55) MAPTTSHRALDH1A1KMT2AACSS2
SCHEMBL2396473 0.80 MAPT (0.50) MAPTNPSR1MAPK1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118838-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2018-06-28 — — WO disclosed
Send feedback